Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models

Cancer Research

Volumn 67, Issue 7, 2007, Pages 3054-3063

  Pisati, Federica ^a,b   Belicchi, Marzia ^a,b   Acerbi, Francesco ^a,b   Marchesi, Chiara ^a,b   Giussani, Carlo ^a,b   Gavina, Manuela ^a,b   Javerzat, Sophie ^a,b   Hagedorn, Martin ^a,b   Carrabba, Giorgio ^a,b   Lucini, Valeria ^a,b   Gaini, Sergio Maria ^a,b   Bresolin, Nereo ^a,b   Bello, Lorenzo ^a,b   Bikfalvi, Andreas ^a,b   Torrente, Yvan ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN TUMOR; CANCER INVASION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CELL; STEM CELL; TUMOR GROWTH; ANIMAL; BIOSYNTHESIS; CELL GROWTH; CHICK EMBRYO; CHORIOALLANTOIS; CYTOLOGY; DRUG SCREENING; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; SKIN; STEM CELL TRANSPLANTATION; TRANSGENIC MOUSE; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; BRAIN NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; GLIOBLASTOMA; HUMANS; MICE; MICE, NUDE; MICE, TRANSGENIC; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; SKIN; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA1; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 34248206277     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-1384     Document Type: Article

References (39)

1. Walker AE, Robins M, Weinfeld FD. Epidemiology of brain tumors: the national survey of intracranical neoplasms. Neurology 1985;35:219-26.
2. Surawicz TS, David F, Freels S, Laws ER, Jr., Mench HR. Brain tumor survival: results from the National Cancer Data Base. J Neurooncol 1998;40:151-60.
3. Schiffer D, Cavalla P, Dutto A. Cell proliferation and invasion in malignant gliomas. Anticancer Res 1997;17: 61-70.
4. Ferrara N. Vascular endothelial growth factor as a target for anticancer theraphy. Oncologist 2004;9 Suppl 1:2-10.
5. Gasparini G, Longo R, Toi M, Ferrara N. Angiogenic inhibitors: a new therapeutic strategy in oncology. Nat Clin Pract 2005;2:562-77.
6. Gee Ms, Koch CJ, Evans SM, et al. Hypoxia-mediated apoptosis from angiogenesis inhibition underlies tumor control by recombinant interleukin 12. Cancer Res 1999; 59:4882-9.
7. Folkman J. Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 1972;75:409-16.
8. Neri D, Bicknell R. Tumor vascular targeting. Nat Rev Cancer 2005;5:436-46.
9. Kerbel RS. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents. Bioessay 1991;13:31-6.
10. Boehm T, Folkman J, Browder T, O'Reilly MS. Anti-angiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997;309-404-7.
11. Benedetti S, Pirola B, Pollo B. Gene therapy of experimental brain tumor using neural progenitor cells. Nat Med 2000;6:447-50.
12. Aboody KS, Brown A, Rainov NG. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial glioma PNAS 2000;97:12846-51.
13. Ehtesham M, Kabos P, Gutierrez MA. Induction of glioblastoma apoptosis using neural stem cells mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 2002;2062:7170-4.
14. Ehtesham M, Kabos P, Kabosova A, Neuman T, Black KL, Yu JS. The use of interleukin 12-secreting neural stem cells for the treatment of intracranical glioma. Cancer Res 2002;62:5657-63.
15. Tocci A, Forte L. Mesenchymal stem cell: use and perspectives. Hematol J 2003;4:92-6.
16. Conget PA, Minguell JJ. Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells. Exp Hematol 2000;28: 382-90.
17. Nakamizo A, Marini F, Amano T, et al. Human bone marrow-derived stem cells in the treatment of gliomas. Cancer Res 2005;65:3307-18.
18. Lee J, Elkahloun AG, Messina SA, et al. Cellular and genetic characterization of human adult bone marrow-derived neural stem-like cells. A potential antiglioma cellular vector. Cancer Res 2003;6:8877-89.
19. Belicchi M, Pisati F, Porretti L, et al. Human skin-derived stem cells migrate throughout forebrain and differentiated into astrocytes after injection into adult mouse brain. J Neuros Res 2004;77:475-86.
20. El Fahime E, Torrente Y, Bresolin N, Tremblay JP. In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity. Exp Cell Res 2001; 258:279-87.
21. Sampaolesi M, Torrente Y, Innocenzi A, et al. Cell therapy of α-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 2003; 25:487-92.
22. Hagedorn M, Javerzat S, Gilges D, et al. Accessing key steps of human tumor progression in vivo by using an avian embryo model. Proc Natl Acad Sci USA 2005;102: 1643-8.
23. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-8.
24. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992;119: 493-501.
25. + stem cells restores dystrophin in mdx mice. J Cell Biol 2001;152: 335-41.
26. Rousseau B, Larrieu-Lahargue F, Javerzat S, Guilhem-Duclèon F, Beermann F, Bikfalvi A. The tyrp1-Tag/tyrp1-1-DN bigenic mouse: a model for selective inhibition of tumor development, angiogenesis, and invasion into the neural tissue by blockade of fibroblast growth factor (FGF) receptor activity. Cancer Res 2004;64: 7181-6.
27. Penna D, Schmidt A, Beermann F. Tumors of the retinal pigment epithelium metastasize to inguinal lymph nodes and spleen in tyrosinase-related protein 1/SV40T antigen transgenic mice. Oncogene 1998;17: 2601-7.
28. Rousseau B, Dubayie D, Sennlaub F, et al. Neural and angiogenic defects in eyes of transgenic mice expressing a dominant-negative FGF receptor in the pigmented cells. Exp Eye Res 2000;71:394-04.
29. Kawase Y, Yanagi Y, Takato T, Fujimoto M, Okochi H. Characterization of multipotent adult stem cells from skin: transforming growth factor-β (TGF-β) facilitates cell growth. Exp Cell Res 2004;295:194-203.
30. Reiss M, Barcellos-Hoff MH. Transforming growth factor-β in breast cancer: a working hypothesis. Breast Cancer Res Treat 1997;45:81-95.
31. Reiss M. TGF-β and cancer. Microbes infect 1999;1: 1327-47.
32. Samuels V, Barret JM, Bockman S, Pantazis CG, Allen MB, Jr. Immunocytochemical study of transforming growth factor-β expression in benign and malignant gliomas. Am J Pathol 1989;134:894-902.
33. Yamada N, Yamashita H, Nister M, et al. Enhanced expression of transforming growth factor-β and its type-I and type-II receptors in human glioblastoma. Int J Cancer 1995;62:386-92.
34. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFβ activation. J Cell Sci 2003;116:217-24.
35. Odeberg J, Piao JH, Samuelsson EB, Falci S, Akesson E. Low immunogenicity of in vitro-expanded human neural cells despite high MHC expression. J Neuroimmunol 2005;161:1-11.
36. Hori J, Ng TF, Shatos M, Klassen H, Streilein JW Young MJ. Neural progenitor cells lack immunogenicity and resist destruction as allografts. Stem Cells 2003;21: 405-16.
37. Armstrong RJ, Harrower TP, Hurelbrink CB, et al. Porcine neural xenografts in the immunocompetent rat: immune response following grafting of expanded neural precursor cells. Neuroscience 2001;106:201-16.
38. Nieda M, Nicol A, Denning-Kendall P, Sweetenham J, Bradley B, Hows J. Endothelial cell precursors are normal components of human umbilical cord blood. Br J Haematol 1997;98:775-7.
39. Marchetti S, Gimond C, Iljin K, et al. Endothelial cells genetically selected from differentiating mouse embryonic stem cells incorporate at sites of neovascularization in vivo. J Cell Sci 2002;115:2075-85.